EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients

Ilies Benotmane, Martin Jungbauer-Groznica, Isabelle Staropoli, Delphine Planas, Océane Dehan, Angela Brisebarre, Etienne Simon-Loriere, Samira Fafi-Kremer, Olivier Schwartz, Timothée Bruel, Sophie Caillard

Transplant International · 2024

DOI: 10.3389/ti.2024.13272 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Transplant International, 2024. Verfasst von Ilies Benotmane und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology Dialysis and Transplantation, Strasbourg University Hospital, Strasbourg, France. Hauptthemen laut MEDLINE: Kidney Transplantation, SARS-CoV-2, Antibodies, Neutralizing, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationSARS-CoV-2Antibodies, NeutralizingCOVID-19Antibodies, MonoclonalHumansAntibodies, ViralMaleTransplant RecipientsMiddle AgedFemale

Stichwörter der Autor:innen

COVID-19SARS-CoV-2immunocompromisedkidney transplant recipientsmonoclonal antibodiessotrovimab

Substanzen

Antibodies, NeutralizingAntibodies, MonoclonalAntibodies, Viral

Autor:innen und Institutionen

  • Department of Nephrology Dialysis and Transplantation, Strasbourg University Hospital, Strasbourg, France.
  • Institut national de la santé et de la recherche médicale (Inserm) UMR S1109, LabEx Transplantex, Fédération de médecine translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
  • Institut Pasteur, Université Paris Cité, Centre national de la recherche scientifique (CNRS) UMR3569, Virus and Immunity Unit, Paris, France.
  • Antiviral Activities of Antibodies Group, Université Paris Cité, Centre national de la recherche scientifique (CNRS) UMR3569, Paris, France.
  • Université Paris Cité, École Doctorale BioSPC 562, Paris, France.
  • Institut Pasteur, Université Paris Cité, G5 Evolutionary Genomics of RNA Viruses, Paris, France.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Benotmane, I., Jungbauer-Groznica, M., Staropoli, I., Planas, D., Dehan, O., Brisebarre, A., Simon-Loriere, E., Fafi-Kremer, S., Schwartz, O., Bruel, T., & Caillard, S. (2024). In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients. Transplant International. https://doi.org/10.3389/ti.2024.13272

Vancouver

Benotmane I, Jungbauer-Groznica M, Staropoli I, Planas D, Dehan O, Brisebarre A, et al. In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients. Transplant International. 2024. doi:10.3389/ti.2024.13272

BibTeX
@article{Benotmane2024,
  author = {Benotmane, Ilies and Jungbauer-Groznica, Martin and Staropoli, Isabelle and Planas, Delphine and Dehan, Océane and Brisebarre, Angela and Simon-Loriere, Etienne and Fafi-Kremer, Samira and Schwartz, Olivier and Bruel, Timothée and Caillard, Sophie},
  title = {In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients},
  journal = {Transplant International},
  year = {2024},
  doi = {10.3389/ti.2024.13272}
}
Kostenlos starten →